The Massachusetts Life Sciences Center and seven global biopharmaceutical companies announced today the opening of the first research solicitation of the Massachusetts Neuroscience Consortium. The Consortium, the formation of which was announced in June at the Bio International Convention, will fund pre-clinical neuroscience research at Massachusetts academic and research institutions. Participating companies include Abbott, Biogen Idec, EMD Serono, Janssen Research & Development, LLC, Merck, Pfizer and Sunovion Pharmaceuticals Inc.
